Evidence map›Paper›PMID 30779799›Full record

ArticlePloS one2019

Spatial and temporal development of deltamethrin resistance in malaria vectors of the Anopheles gambiae complex from North Cameroon.

Stanislas Elysée Mandeng, Herman Parfait Awono-Ambene, Jude D Bigoga, Wolfgang Eyisap Ekoko, Jérome Binyang, Michael Piameu, Lili Ranaise Mbakop, Betrand Nono Fesuh, Narcisse Mvondo, Raymond Tabue and 9 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
5.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Mechanisms of carbamate resistance in the malaria vector:Parasite epidemiology and control · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Larviciding intervention targeting malaria vectors also affectsCurrent research in parasitology & vector-borne diseases · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Patterns ofPathogens (Basel, Switzerland) · 2022
    Article
  14. Review
  15. Pyrethroid and Etofenprox Resistance inMolecules (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 6 countries.

Stanislas Elysée MandengInstitut de Recherche de Yaoundé (IRY), Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.
Herman Parfait Awono-AmbeneInstitut de Recherche de Yaoundé (IRY), Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.
Jude D BigogaLaboratory for Vector Biology and control, National Reference Unit for Vector Control, The Biotechnology Center, Nkolbisson-University of Yaounde I, Yaounde, Cameroon.
Wolfgang Eyisap EkokoInstitut de Recherche de Yaoundé (IRY), Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.
Jérome BinyangLaboratory of General Biology, University of Yaounde I, Yaounde, Cameroon.
Michael PiameuInstitut de Recherche de Yaoundé (IRY), Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.
Lili Ranaise MbakopInstitut de Recherche de Yaoundé (IRY), Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.
Betrand Nono FesuhNational Advanced School of Engineering, University of Yaounde I, Yaounde, Cameroon.
Narcisse MvondoLaboratory of General Biology, University of Yaounde I, Yaounde, Cameroon.
Raymond TabueLaboratory for Vector Biology and control, National Reference Unit for Vector Control, The Biotechnology Center, Nkolbisson-University of Yaounde I, Yaounde, Cameroon.
Philippe NwaneInstitut de Recherche de Yaoundé (IRY), Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.
Rémy MimpfoundiLaboratory of General Biology, University of Yaounde I, Yaounde, Cameroon.
Jean Claude TotoInstitut de Recherche de Yaoundé (IRY), Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.
Immo KleinschmidtDepartment of Infectious Disease Epidemiology, London School of Tropical Medicine & Hygiene, MRC Tropical Epidemiology Group, London, United Kingdom.
Tessa Bellamy KnoxGlobal Malaria Programme, World Health Organization, Geneva, Switzerland.
Abraham Peter MnzavaAfrican Leaders Malaria Alliance (ALMA), Dar es Salaam, Tanzania.
Martin James DonnellyDepartment of Vector Biology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
Etienne FondjoMinistry of Public Health, National Malaria Control Programme, Yaounde, Cameroon.
Josiane EtangInstitut de Recherche de Yaoundé (IRY), Organisation de Coordination pour la lutte contre les Endémies en Afrique Centrale (OCEAC), Yaoundé, Cameroon.ORCID 0000-0001-8953-0419
Université de Yaoundé I · CMOrganisation de Coordination pour la lutte contre les Endémies en Afrique Centrale · CMUniversity of Douala · CMAfrican Malaria Network Trust · TZLiverpool School of Tropical Medicine · GBMinistry of Public Health · CMUniversity of the Witwatersrand · ZAWorld Health Organization · CH

Funding

Medical Research Council MR/K012126/1Medical Research Council MR/R010161/1World Health Organization 001
6 · The paper itself

Abstract

The effectiveness of insecticide-based malaria vector control interventions in Africa is threatened by the spread and intensification of pyrethroid resistance in targeted mosquito populations. The present study aimed at investigating the temporal and spatial dynamics of deltamethrin resistance in An. gambiae s.l. populations from North Cameroon. Mosquito larvae were collected from 24 settings of the Garoua, Pitoa and Mayo Oulo Health Districts (HDs) from 2011 to 2015. Two to five days old female An. gambiae s.l. emerging from larval collections were tested for deltamethrin resistance using the World Health Organization's (WHO) standard protocol. Sub samples of test mosquitoes were identified to species using PCR-RFLP and genotyped for knockdown resistance alleles (Kdr 1014F and 1014S) using Hot Ligation Oligonucleotide Assay (HOLA). All the tested mosquitoes were identified as belonging to the An. gambiae complex, including 3 sibling species mostly represented by Anopheles arabiensis (67.6%), followed by Anopheles coluzzii (25.4%) and Anopheles gambiae (7%). Deltamethrin resistance frequencies increased significantly between 2011 and 2015, with mosquito mortality rates declining from 70-85% to 49-73% in the three HDs (Jonckheere-Terstra test statistic (JT) = 5638, P< 0.001), although a temporary increase of mortality rates (91-97%) was seen in the Pitoa and Mayo Oulo HDs in 2012. Overall, confirmed resistance emerged in 10 An. gambiae s.l. populations over the 24 field populations monitored during the study period, from 2011 to 2015. Phenotypic resistance was mostly found in urban settings compared with semi-urban and rural settings (JT = 5282, P< 0.0001), with a spatial autocorrelation between neighboring localities. The Kdr 1014F allelic frequencies in study HDs increased from 0-30% in 2011 to 18-61% in 2014-2015 (JT = 620, P <0.001), especially in An. coluzzii samples. The overall frequency of the Kdr 1014S allele was 0.1%. This study revealed a rapid increase and widespread deltamethrin resistance frequency as well as Kdr 1014F allelic frequencies in An. gambiae s.l. populations over time, emphasizing the urgent need for vector surveillance and insecticide resistance management strategies in Cameroon.

Indexed as

Insecticide ResistanceAnimalsAnophelesCameroonFemaleGene FrequencyInsect ProteinsLarvaMalariaMosquito VectorsNitrilesPyrethrinsSocial PlanningSpatio-Temporal AnalysisUrban RenewaldecamethrinInsect ProteinsNitrilesPyrethrins

Identifiers

PMID30779799
PMCPMC6380565
OpenAlexW2916051300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.